| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
Departments of 1 Pathology, 2 Experimental Therapeutics, and 3 Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Jinsong Liu, Department of Pathology, Unit 85, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4095. Phone: 713-745-1102; Fax: 713-792-5529; E-mail: jliu{at}mdanderson.org.
Purpose: The cyclin-dependent kinase inhibitor p27kip1 regulates cellular progression from G1 to S phase. Several studies have shown that loss of p27kip1 protein expression is associated with disease progression in various malignancies. The purpose of this study was to evaluate the subcellular localization of this cyclin-dependent kinase inhibitor in a large cohort of primary ovarian carcinomas and compare the results with clinicopathologic variables and overall survival.
Experimental Design: Subcellular localization of p27kip1 was first assessed by Western blotting in nuclear and cytoplasmic extract from 13 cases of ovarian carcinoma. Subcellular localization of the p27kip1 protein was evaluated using tissue microarrays containing 421 cases of ovarian carcinoma.
Results: The presence of p27kip1 in the cytoplasm regardless of the nuclear stain correlated strongly with late-stage disease (P < 0.03), extent of cytoreduction (P = 0.03), and shorter disease-specific survival (P < 0.0001).
Conclusion: Cytoplasmic localization of p27kip1 predicts poorer prognosis in ovarian carcinoma, particularly in late-stage disease.
Key Words: p27kip1 • tissue microarray; prognostic marker • prognostic marker • ovarian cancer
This article has been cited by other articles:
|
|
 |
|
  M. D. Larrea, F. Hong, S. A. Wander, T. G. da Silva, D. Helfman, D. Lannigan, J. A. Smith, and J. M. Slingerland RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility PNAS, June 9, 2009; 106(23): 9268 - 9273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. HIDAKA, S. HAMA, P. SHRESTHA, T. SAITO, Y. KAJIWARA, F. YAMASAKI, K. SUGIYAMA, and K. KURISU The Combination of Low Cytoplasmic and High Nuclear Expression of p27 Predicts a Better Prognosis in High-grade Astrocytoma Anticancer Res, February 1, 2009; 29(2): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bartholomeusz, D. Rosen, C. Wei, A. Kazansky, F. Yamasaki, T. Takahashi, H. Itamochi, S. Kondo, J. Liu, and N. T. Ueno PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival Cancer Res., November 15, 2008; 68(22): 9302 - 9310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Denicourt, C. C. Saenz, B. Datnow, X.-S. Cui, and S. F. Dowdy Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma Cancer Res., October 1, 2007; 67(19): 9238 - 9243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Besson, H. C. Hwang, S. Cicero, S. L. Donovan, M. Gurian-West, D. Johnson, B. E. Clurman, M. A. Dyer, and J. M. Roberts Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype Genes & Dev., July 15, 2007; 21(14): 1731 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Goyeneche, R. W. Caron, and C. M. Telleria Mifepristone Inhibits Ovarian Cancer Cell Growth In vitro and In vivo Clin. Cancer Res., June 1, 2007; 13(11): 3370 - 3379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yang, D. G. Rosen, Z. Zhang, R. C. Bast Jr., G. B. Mills, J. A. Colacino, I. Mercado-Uribe, and J. Liu The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis PNAS, October 31, 2006; 103(44): 16472 - 16477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Jakoby, C. Weinl, S. Pusch, S. J.H. Kuijt, T. Merkle, N. Dissmeyer, and A. Schnittger Analysis of the Subcellular Localization, Function, and Proteolytic Control of the Arabidopsis Cyclin-Dependent Kinase Inhibitor ICK1/KRP1 Plant Physiology, August 1, 2006; 141(4): 1293 - 1305. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
